Digital Therapy for Cancer Pain

Recruiting in Palo Alto (17 mi)

Overseen byDesiree Azizoddine, PsyD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Dana-Farber Cancer Institute

No Placebo Group

Trial Summary

What is the purpose of this trial?

Smartphone Technology to Alleviate Malignant Pain (STAMP) + Cognitive Behavioral Therapy for Pain (STAMP+CBT) The purpose of the study is to develop and refine the mHealth pain-CBT app intervention and carry out a randomized pilot to test the novel mHealth (Mobile health technology) intervention, which harmonizes psychological and pharmacological support for advanced cancer pain. The name of the study smartphone application involved in this study is: -STAMP+CBT

Research Team

Desiree Azizoddine, PsyD

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

This trial is for adults over 22 with chronic pain from advanced cancer, who use a smartphone and take opioid medication for cancer pain. It's not for those who don't speak English, have cognitive issues, are hospitalized or in hospice care, currently in CBT treatment, or whose pain is from recent surgery.

Inclusion Criteria

I am 22 years old or older.

I experience chronic pain from cancer or its treatment, with a pain level above 4.

I am currently being treated for an advanced cancer or receiving care to ease cancer symptoms.

See 2 more

Exclusion Criteria

I can communicate effectively in English.

Conditions that hinder smartphone use

I have completed my cancer treatment and am not currently receiving treatment for advanced cancer.

See 7 more

Treatment Details

Interventions

STAMP + CBT (Behavioral Intervention)

Trial OverviewThe STAMP+CBT mobile app is being tested to see if it can help manage cancer-related chronic pain by combining psychological support (CBT) with guidance on using pain medications effectively through a digital platform.

Participant Groups

2Treatment groups

Experimental Treatment

Group I: Cohort D: Digital Cancer Pain Education Packet + Usual CareExperimental Treatment1 Intervention

Permutated-block randomization and a block size of 6 will be used to randomize 60 participants to this cohort, and participants will complete: * Baseline in-person or remote visit with introduction to the digital cancer pain education packet and pain tracker form. * Completion of pain tracker * Day 7 check in with study team * Day 14 survey * Day 28 surveys * Optional in-person or remote semi-structured, exit interview to review the educational packet * Day 42 (Week 6) follow-up survey

Group II: Cohort C: STAMP + CBT AppExperimental Treatment1 Intervention

Permutated-block randomization and a block size of 6 will be used to randomize 60 participants to this cohort, and participants will complete: * Baseline in-person or remote visit with an introduction to the STAMP+CBT application. * Surveys via the application 6 days per week. * Day 7 check in with study team * Day 14 survey * Day 28 follow-up surveys * Optional in-person or remote semi-structured, exit interview * Day 42 (Week 6) follow-up survey